Showing results (231-240 of 399) with videos related to
Sort By:
Pageof 40
Cancer Research Communications|August 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung CancerTakahiko Murayama, Navin R Mahadevan, Catherine B Meador, et al.Journal of Hematology & Oncology|January 7, 2022
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.Leukemia|March 30, 2019
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapyAreej El-Jawahri, Gregory A Abel, Lara Traeger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction CorrelatesEvan C Chen, Helen Gandler, Isidora Tošić, et al.Leukemia Research|July 25, 2025
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control studyAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.Leukemia|February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AMLShai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.Cancer Immunology Research|September 23, 2018
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell KillingPatrick H Lizotte, Ruey-Long Hong, Troy A Luster, et al.Pageof 40